DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Investment/Miscellaneous Eckert & Ziegler subscribes to capital increase at BEBIG 25.04.2016 / 19:33 The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Berlin / Seneffe, April 25, 2016. At today's meeting, the Board of Directors of Eckert & Ziegler BEBIG s.a. in Belgium resolved to propose to the Annual General Meeting on June 9, 2016 a capital increase with the exclusion of subscription rights of minority shareholders. Eckert & Ziegler AG, which already owns just under 75% of the dividend-bearing shares, will be the subscriber. With this subscription, the company will increase its shareholding to around 80%. The planned capital inflow of some EUR 5 million is intended to strengthen the equity base and will be used to repay debt. More details on the capital increase are available in the press release published by Eckert & Ziegler BEBIG s.a. on its website: http://www.bebig.com/international/press/press-releases.html With around 700 employees, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is one of the world's largest providers of isotope technology components for radiation therapy and nuclear medicine. For further information or questions, please contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin, Germany Tel.: +49 30 941084-138, [email protected] www.ezag.de --------------------------------------------------------------------------- 25.04.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Eckert & Ziegler Strahlenund Medizintechnik AG Robert-Rössle-Str.10 13125 Berlin Germany Phone: 49 30 941084-138 Fax: 49 30 941084-112 E-mail: [email protected] Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Listed: Regulated Market in Frankfurt (Prime Standard), Stuttgart; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich End of News DGAP News Service --------------------------------------------------------------------------- 457565 25.04.2016